APA (7th ed.) Citation

RD, H., GE, R., RF, B., GF, P., G, E., PD, S., . . . AF, M. (2000). Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Archives of internal medicine, 160(2), 229. https://doi.org/10.1001/archinte.160.2.229

Chicago Style (17th ed.) Citation

RD, Hull, Raskob GE, Brant RF, Pineo GF, Elliott G, Stein PD, Gottschalk A, Valentine KA, and Mah AF. "Low-molecular-weight Heparin Vs Heparin in the Treatment of Patients with Pulmonary Embolism. American-Canadian Thrombosis Study Group." Archives of Internal Medicine 160, no. 2 (2000): 229. https://doi.org/10.1001/archinte.160.2.229.

MLA (9th ed.) Citation

RD, Hull, et al. "Low-molecular-weight Heparin Vs Heparin in the Treatment of Patients with Pulmonary Embolism. American-Canadian Thrombosis Study Group." Archives of Internal Medicine, vol. 160, no. 2, 2000, p. 229, https://doi.org/10.1001/archinte.160.2.229.